Royal Bank of Canada’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56M | Buy |
707,226
+683,864
| +2,927% | +$3.45M | ﹤0.01% | 2602 |
|
|
2025
Q1 | $152K | Buy |
23,362
+7,476
| +47% | +$48.6K | ﹤0.01% | 4562 |
|
|
2024
Q4 | $117K | Buy |
15,886
+3,435
| +28% | +$25.3K | ﹤0.01% | 4783 |
|
|
2024
Q3 | $94K | Buy |
12,451
+2,036
| +20% | +$15.4K | ﹤0.01% | 4936 |
|
|
2024
Q2 | $93K | Buy |
10,415
+4,946
| +90% | +$44.2K | ﹤0.01% | 4925 |
|
|
2024
Q1 | $55K | Sell |
5,469
-22,630
| -81% | -$228K | ﹤0.01% | 5062 |
|
|
2023
Q4 | $283K | Buy |
28,099
+9,842
| +54% | +$99.1K | ﹤0.01% | 4273 |
|
|
2023
Q3 | $171K | Buy |
18,257
+5,579
| +44% | +$52.3K | ﹤0.01% | 4470 |
|
|
2023
Q2 | $311K | Buy |
12,678
+3,713
| +41% | +$91.1K | ﹤0.01% | 3952 |
|
|
2023
Q1 | $208K | Sell |
8,965
-5,233
| -37% | -$121K | ﹤0.01% | 4233 |
|
|
2022
Q4 | $360K | Buy |
14,198
+10,073
| +244% | +$255K | ﹤0.01% | 3950 |
|
|
2022
Q3 | $79K | Buy |
4,125
+510
| +14% | +$9.77K | ﹤0.01% | 4986 |
|
|
2022
Q2 | $92K | Sell |
3,615
-9,638
| -73% | -$245K | ﹤0.01% | 4934 |
|
|
2022
Q1 | $341K | Sell |
13,253
-725
| -5% | -$18.7K | ﹤0.01% | 4150 |
|
|
2021
Q4 | $585K | Buy |
13,978
+13,728
| +5,491% | +$575K | ﹤0.01% | 3840 |
|
|
2021
Q3 | $11K | Hold |
250
| – | – | ﹤0.01% | 6414 |
|
|
2021
Q2 | $12K | Sell |
250
-2,118
| -89% | -$102K | ﹤0.01% | 6306 |
|
|
2021
Q1 | $121K | Buy |
2,368
+2,213
| +1,428% | +$113K | ﹤0.01% | 4849 |
|
|
2020
Q4 | $4K | Sell |
155
-21
| -12% | -$542 | ﹤0.01% | 6194 |
|
|
2020
Q3 | $6K | Sell |
176
-74
| -30% | -$2.52K | ﹤0.01% | 5607 |
|
|
2020
Q2 | $10K | Buy |
250
+34
| +16% | +$1.36K | ﹤0.01% | 5362 |
|
|
2020
Q1 | $7K | Sell |
216
-287
| -57% | -$9.3K | ﹤0.01% | 5450 |
|
|
2019
Q4 | $6K | Buy |
+503
| New | +$6K | ﹤0.01% | 5705 |
|